About this Research Topic
We are pleased to introduce the Thoracic Oncology Chief Editor's Pick for Quarter 1 2021. This collection showcases carefully selected articles published in the section over the previous quarter.
The work exhibited here spotlights the high-quality and diverse research carried out globally and brings attention to recent areas of interest and advances within the field. The collection not only supports the work of the authors who have contributed their outstanding research to the journal, but also recognizes the hard work of our Editorial Board of international researchers who contribute to the peer-review of such articles.
The Thoracic Oncology Section of Frontiers in Oncology aims to advance the understanding of the underlying biology of thoracic malignancies, the changing epidemiology of these diseases, advances in diagnostic sciences, biomarker development, and therapeutic approaches of various modalities.
Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.
The work exhibited here spotlights the high-quality and diverse research carried out globally and brings attention to recent areas of interest and advances within the field. The collection not only supports the work of the authors who have contributed their outstanding research to the journal, but also recognizes the hard work of our Editorial Board of international researchers who contribute to the peer-review of such articles.
The Thoracic Oncology Section of Frontiers in Oncology aims to advance the understanding of the underlying biology of thoracic malignancies, the changing epidemiology of these diseases, advances in diagnostic sciences, biomarker development, and therapeutic approaches of various modalities.
Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.
Keywords: thoracic oncology, lung cancer, thymic epithelial tumors, NSCLC, Biomarkers
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
